1. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein;Beasley;J. Virol.,2002
2. Case, D.A., Pearlman, D.A., Caldwell, J.W., Cheatham, T.E., III, Ros, W.S., Simmerling, C.L., Darden, T.A., Merz, K.M., Standon, R.V., Cheng, A.L., Vincent, J.J., Crowly, M., Tsui, V., Radmer, R.J., Duan, Y., Pitera, J., Massova, I., Seibel, G.L., Singh, U.C., Weiner, P.K., Kollman, P.A. 1999. AMBER6, University of California, San Francisco.
3. Cecilia, D., Gould, E.A., 1991. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology 181, 70–77.
4. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein;Chu;J. Gen. Virol.,2005
5. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells;Crill;J. Virol.,2001